InnoCentive Expands Global Scientific Community with Ciba and Novartis

Strategic Insights -

InnoCentive, an online scientific forum, has welcomed Ciba Specialty Chemicals and Novartis Pharma AG as its latest Seeker members. This collaboration enables these global companies to tap into the expertise of top scientific minds and significantly enhance their research initiatives. The InnoCentive community, comprising over 80,000 scientists and researchers in 175 countries, will contribute to delivering cutting-edge solutions to customers.

Key Takeaways:

  • InnoCentive has welcomed Ciba Specialty Chemicals and Novartis Pharma AG as its latest Seeker members, expanding its global scientific community.
  • The collaboration will enable these companies to leverage the expertise of top scientific minds and enhance their research initiatives.
  • Seeker companies, including Ciba and Novartis, will post challenges on InnoCentive's confidential website, www.innocentive.com, and receive solutions from over 80,000 scientists worldwide.
  • Solvers who deliver solutions that best meet InnoCentive's challenge requirements will receive financial awards ranging up to USD$100,000.
  • InnoCentive has already established relationships with leading companies like Boeing, Dow, DuPont, Eli Lilly and Company, and Procter & Gamble, and has recently renewed its contract with Dow.
  • The company's vice president of marketing, Ali Hussein, stated that InnoCentive continues to connect leading companies to the brightest scientists worldwide, expanding its online global forum rapidly.
  • Ciba Specialty Chemicals will use InnoCentive's community of Solvers to add creativity to its research efforts, while Novartis Pharma AG will leverage InnoCentive's network to enhance its current R&D initiatives.
  • InnoCentive's CEO, Darren J. Carroll, expressed delight at welcoming global leaders like Ciba and Novartis to its online network, emphasizing the company's commitment to contributing to the success of its Seeker clients.

Statistics:

  • InnoCentive's global scientific community comprises over 80,000 scientists and researchers in 175 countries.
  • The platform allows Seeker companies to post challenges and receive solutions from experts worldwide.
  • Solvers can receive financial awards of up to USD$100,000 for delivering solutions that meet InnoCentive's challenge requirements.
  • InnoCentive has already established relationships with leading companies like Boeing, Dow, DuPont, Eli Lilly and Company, and Procter & Gamble.
  • The company's platform has expanded rapidly, with the number of Seeker companies and Solvers continuously growing.

Sources:

  • "InnoCentive announced Ciba Specialty Chemicals and Novartis Pharma AG have joined its online scientific forum." (Source: PRNewswire-AsiaNet)
  • "InnoCentive is the first online forum that allows world-class scientists and science-based companies to collaborate in a global scientific community to achieve innovative solutions to complex challenges." (Source: InnoCentive)
  • "Ciba Specialty Chemicals is a leading global company dedicated to producing high-value effects for its customers' products." (Source: Ciba Specialty Chemicals)
  • "Dow is a leader in science and technology, providing innovative chemical, plastic and agricultural products and services to many essential consumer markets." (Source: Dow)